We did not find a trend in the risk of these subtypes of breast cancer with the increased age at menopause (multivariate‐adjusted Ptrend = .90 for HER2‐overexpressing and Ptrend = .50 for triple‐negative breast cancer). This evidence concerns the gene ERBB2 and breast cancer.